Most direct-to-consumer brands measure success in headcount growth. Reformed measures it in headcount restraint.
The London-based functional coffee company recently crossed $70 million in annualized revenue—in roughly 20 months, with a team of just 14 people. That works out to about $5 million in revenue per employee, a ratio that defies conventional wisdom in consumer packaged goods. For context, most high-growth DTC brands at this scale employ triple that number, sometimes more.
The company closed a $22 million Series A in July 2026 to bring what it calls "the coffee upgrade" to the United States. IRIS Ventures led the round, with participation from JamJar Investments, V3 Ventures, and FoodLabs—investors betting that Reformed's formula can translate across the Atlantic. Whether it actually will is another question entirely.
The Founders Who Refuse to Hire
Neil Saada and Neil Marrakchi are both in their mid-twenties. They launched Reformed in April 2024 after spending time on formulation and supply chain—the company incorporated in July 2023. Saada was appointed as a director on November 6, 2024, and Marrakchi on December 10, 2024. When they finally went to market, they did so with a premise that sounds obvious in hindsight: don't ask people to adopt a new habit. Upgrade the one they already have.
Reformed sells instant coffee and ceremonial-grade matcha loaded with functional ingredients. We're talking 15 grams of collagen or 5 grams of creatine per serving, plus lion's mane mushrooms, chaga, MCT oil, and a 21-vitamin blend sourced from whole foods. Pricing starts at £39.99 per pouch in the UK. You can also find it at Selfridges, though the real business happens online.
The functional coffee category is crowded to the point of parody. What set Reformed apart wasn't the ingredient list—it was the positioning. Instead of marketing their products as a coffee alternative (the wellness industry's favorite euphemism for "thing you won't actually drink"), they framed it as an upgrade to the morning ritual people already refuse to skip. Subtle difference. Apparently meaningful.
By the time of the funding announcement, roughly half of Reformed's revenue came from repeat customers. More striking: about 80% of subscribers placed a second order by their second monthly renewal. Those are retention numbers that make most subscription companies weep into their spreadsheets.
Lean by Design, Not by Accident
The 14-person headcount isn't a bootstrap phase Reformed plans to grow out of. It appears to be the operating model, at least for now.
The company runs its own production facility in the UK, which gives it control over quality and margins—two things that matter when you're trying to stay profitable. Reformed reports hitting profitability, though the specific type of profitability—whether contribution-margin positive, EBITDA positive, or something else—hasn't been disclosed. The company filed micro accounts with Companies House, so detailed financials remain private. Profitability claims without specifics are data points, not proof.
Still, the efficiency is real. Fourteen people can't manually handle $70 million worth of customer service, fulfillment, creative production, and operations. Reformed almost certainly relies on heavy automation, outsourced logistics, and ruthless prioritization about what not to do. Recent job postings visible through the founders' LinkedIn profiles suggest they're adding capacity selectively: a CRM and retention manager here, a creative strategist there. High-leverage roles only.
For the U.S. expansion, Reformed plans to work with local manufacturing partners rather than ship inventory overseas. Smart for unit economics. Also introduces new supplier relationships to manage, new regulatory hurdles to clear, and new quality-control challenges. The FDA takes a different view of health claims than UK regulators do, and Reformed will need to navigate that carefully.
The Subscription Bet
Reformed's core channel is direct-to-consumer subscriptions, which isn't novel. What matters is how central the subscription model became to everything else. Monthly deliveries created predictable cash flow. Predictable cash flow allowed the team to stay lean. Staying lean kept burn low. Low burn meant less need for venture capital until the business had real momentum.
The product lineup includes coffee and matcha, each available with collagen or creatine, plus flavored matcha variants in vanilla, blueberry, strawberry, and coconut. There are vegan collagen SKUs too. The coffee delivers 78 milligrams of caffeine per serving; the mocha variant has 46. According to the company's website, Reformed's collagen carries Halal and Kosher certifications, and the brand positions itself as gluten-free, dairy-free, refined-sugar-free, and paleo-friendly—checking boxes across dietary tribes.
The dosages are high enough to matter. Fifteen grams of collagen per serving is competitive with standalone supplements. But the real insight is bundling functional ingredients into a ritual people already perform on autopilot. Whether those functional claims will hold up under U.S. regulatory scrutiny is an open question. Health and structure-function claims face stricter rules stateside.
Selfridges provides a physical proof point in the UK, but the DTC channel is where Reformed has built what passes for a moat in consumer goods. Selling directly means owning the customer relationship, controlling the narrative, and capturing full margin. It also means you have to nail retention or die trying.
Growth That Raises Eyebrows
Reformed's growth trajectory, if the numbers are accurate, is striking. Forbes reported the company hit $27 million in ARR within under 22 months of launch. By the 20-month mark, that figure had reached $70 million.
That kind of acceleration implies either a step-function increase in marketing spend, a viral moment, or both. Reformed hasn't broken out customer acquisition costs or lifetime value publicly, so judging the sustainability of that growth is difficult from the outside. The company raised about $4 million in earlier funding from investors including FoodLabs before the Series A, which would have provided fuel for customer acquisition. How much fuel, and at what cost, remains unclear.
The subscription model provides some cushion. If Reformed's retention metrics hold, that $70 million in ARR isn't starting from zero each month. But subscription brands live and die by churn, and Reformed will need to prove it can maintain those numbers as it scales into new markets with different customer bases.
The American Gamble
The $22 million Series A is earmarked for U.S. expansion and international growth. Both founders are relocating to lead the charge, which suggests they're serious. The U.S. functional beverage market is larger than the UK's but also more competitive. Established players dominate both retail and DTC channels. Reformed will need to crack distribution, navigate different regulatory frameworks, and likely invest heavily in brand-building to cut through the noise.
Local manufacturing partnerships in the U.S. should help with logistics and tariffs, but they also introduce complexity. New suppliers. New quality-control challenges. New cost structures to optimize.
If Reformed can replicate its UK retention metrics in the U.S., the subscription model gives it a fighting chance. American coffee drinkers are particular about their morning routines, perhaps more so than their British counterparts. Whether they'll buy the upgrade—literally and figuratively—will determine if Reformed's efficiency story scales or stalls.
For now, Reformed remains a case study in doing more with less. Whether that's a sustainable competitive advantage or a temporary phase before the company needs to hire like everyone else is a question for later innings. The founders, for their part, seem determined to find out.
